Merck Total Non-Operating Income/Expense 2010-2024 | MRK

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Merck annual total non-operating income/expense for 2024 was $-0.285B, a 73.24% decline from 2023.
Merck annual total non-operating income/expense for 2023 was $-1.065B, a 42.06% decline from 2022.
Merck annual total non-operating income/expense for 2022 was $-1.838B, a 370.29% decline from 2021.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Merck annual total non-operating income/expense for 2024 was $-0.285B, a 73.24% decline from 2023.
Merck annual total non-operating income/expense for 2023 was $-1.065B, a 42.06% decline from 2022.
Merck annual total non-operating income/expense for 2022 was $-1.838B, a 370.29% decline from 2021.